S. Sheetikov

发表

Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia

G. Efimov, D. Lioznov, T. Zhu, 2022, medRxiv.

Clonal diversity determines persistence of SARS-CoV-2 epitope-specific T cell response

A. Titov, G. Efimov, I. Zvyagin, 2022, medRxiv.

Immunogenic epitope panel for accurate detection of non-cross-reactive T cell response to SARS-CoV-2

A. Tonevitsky, M. Shkurnikov, A. Titov, 2021, medRxiv.

Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y

G. Efimov, A. Kuchmiy, S. Filkin, 2019, Molecular Biology.

SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors

G. A. Efimov, A. Titov, G. Efimov, 2020, Immunity.

Clonal diversity predicts persistence of SARS-CoV-2 epitope-specific T-cell response

A. Titov, G. Efimov, I. Zvyagin, 2022, Communications biology.

Recombinant MHC tetramers for isolation of virus-specific CD8+ cells from healthy donors: Potential approach for cell therapy of posttransplant cytomegalovirus infection

G. Efimov, E. Parovichnikova, V. Savchenko, 2016, Biochemistry (Moscow).

Transgenic HA-1-Specific CD8+ T-Lymphocytes Selectively Target Leukemic Cells

G. Efimov, M. Vagida, A. Gabashvili, 2023, Cancers.

A prospective study of the protective effect of SARS-CoV-2-specific antibodies and T cells in Moscow residents

A. Mohammad, N. Pinegina, A. Deryabin, 2021, medRxiv.

Modification of Cytotoxic Lymphocytes with T Cell Receptor Specific for Minor Histocompatibility Antigen ACC-1Y

G. Efimov, A. Kuchmiy, S. Filkin, 2019, Molecular Biology.

rs71327024 Associated with COVID-19 Hospitalization Reduces CXCR6 Promoter Activity in Human CD4+ T Cells via Disruption of c-Myb Binding

K. V. Korneev, I. Kulakovskiy, K. Korneev, 2023, International journal of molecular sciences.